HLB Pharmaceutical Co., Ltd (047920.KQ)

KRW 23050.0

(-1.5%)

Total Assets Summary of HLB Pharmaceutical Co., Ltd

  • HLB Pharmaceutical Co., Ltd's latest annual total assets in 2023 was 141.35 Billion KRW , down -0.58% from previous year.
  • HLB Pharmaceutical Co., Ltd's latest quarterly total assets in 2024 Q2 was 157.45 Billion KRW , down -7.72% from previous quarter.
  • HLB Pharmaceutical Co., Ltd reported annual total assets of 142.17 Billion KRW in 2022, up 11.4% from previous year.
  • HLB Pharmaceutical Co., Ltd reported annual total assets of 127.63 Billion KRW in 2021, up 14.55% from previous year.
  • HLB Pharmaceutical Co., Ltd reported quarterly total assets of 170.63 Billion KRW for 2024 Q1, up 20.72% from previous quarter.
  • HLB Pharmaceutical Co., Ltd reported quarterly total assets of 146 Billion KRW for 2023 Q2, down -1.25% from previous quarter.

Annual Total Assets Chart of HLB Pharmaceutical Co., Ltd (2023 - 2016)

Historical Annual Total Assets of HLB Pharmaceutical Co., Ltd (2023 - 2016)

Year Total Assets Total Assets Growth
2023 141.35 Billion KRW -0.58%
2022 142.17 Billion KRW 11.4%
2021 127.63 Billion KRW 14.55%
2020 111.41 Billion KRW 143.03%
2019 45.84 Billion KRW 25.87%
2018 36.42 Billion KRW -8.59%
2017 39.84 Billion KRW -6.01%
2016 42.39 Billion KRW 0.0%

Peer Total Assets Comparison of HLB Pharmaceutical Co., Ltd

Name Total Assets Total Assets Difference
CMG Pharmaceutical Co., Ltd. 186.85 Billion KRW 24.351%
Celltrion Pharm, Inc. 641.64 Billion KRW 77.97%
Huons Global Co., Ltd. 1317.96 Billion KRW 89.275%
DongKook Pharmaceutical Co., Ltd. 839.53 Billion KRW 83.163%
Enzychem Lifesciences Corporation 211.54 Billion KRW 33.181%
Humedix Co., Ltd. 219.97 Billion KRW 35.743%
Boditech Med Inc. 227.9 Billion KRW 37.977%
EuBiologics Co., Ltd. 172.64 Billion KRW 18.124%
FutureChem Co.,Ltd 72.83 Billion KRW -94.076%
Huons Co., Ltd. 537.28 Billion KRW 73.692%
BNC Korea Co., Ltd. 236.15 Billion KRW 40.144%
AptaBio Therapeutics Inc. 92.51 Billion KRW -52.781%